期刊文献+

甲基睾丸素联合米非司酮治疗更年期功血的疗效观察

Effect of methyl testosterone and mifepristone in menopausal dysfunctional uterine bleeding
暂未订购
导出
摘要 目的:探讨甲基睾丸素联合米非司酮治疗更年期功能失调性子宫出血(功血)的临床疗效。方法:将56例更年期功血患者随机分组,对照组每日口服米非司酮12.5mg,连续服用3个月;治疗组每日口服米非司酮10mg+甲基睾丸素10mg,连续服用3个月,门诊随访观察用药疗效。结果:治疗组与对照组治疗更年期功血均具有良好的治疗效果,血清促卵泡刺激素(FSH)、黄体生成素(LH)和孕酮(P)较治疗前均呈现显著性降低(P<0.05),且治疗组疗效略优于对照组,治疗组不良反应发生率明显低于对照组。结论:甲基睾丸素联合米非司酮治疗更年期功血疗效略优于单独给予米非司酮。 Objective: To explore the curative effect of methyl testosterone and mifepristone in menopausal dysfunctional uterine bleeding. Methods: 56 patients of menopausal dysfunctional uterine bleeding were divided into therapy group and control group. Control group were treated with mifepristone 12.5 mg/d for 3 months. Therapy group were treated with mifepristone 10 mg/d and methyl testosterone 10 mg/d for 3 months. Follow-up with outpatient for efficacy. Results: The effect of therapy group was better than that in the control group. Serum follicle stimulating hormone (FSH), luteinizing hormone (LH) and progesterone (P) all significantly decreased than before treatment (P0.05); and the effect of therapy group was slightly better than the control group, adverse reactions were significantly lower than the control group. Conclusion: Effect of methyl testosterone combined mifepristone in the treatment of menopausal uterine bleeding is slightly better than mifepristone alone.
出处 《中国当代医药》 2011年第30期41-42,共2页 China Modern Medicine
关键词 甲基睾丸素 米非司酮 更年期功能失调性子宫出血 疗效观察 Methyl testosterone Mifepristone Menopausal dysfunctional uterine bleeding Effect observation
  • 相关文献

参考文献6

二级参考文献32

  • 1张雪莲,倪江,罗宏志,刘润梅,吴嬿婉,李伟雄,程治平.酪氨酸、米非司酮和睾酮对大鼠颗粒细胞凋亡的影响[J].生殖医学杂志,1995,4(3):142-145. 被引量:116
  • 2朱四军,赵白鸽,谢衷明.RU486对下丘脑-垂体-卵巢-子宫内膜轴的功能影响[J].生殖与避孕,1995,15(4):243-248. 被引量:293
  • 3Taylor RN,Lebovic DI,Hornung D,et al.Endocrine and paracrine regulation of endometrial angiogenesis.Ann N Y.Acad Sci,2001,943:109-121.
  • 4Kooy J,Taylor NH,Healy DL,et al.Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation.Hum Reprod,1996,11(5):1067-1072
  • 5Rogers PA,Lederman F,Taloy N.Endometrial microvascular growth in normal and dysfunctional states.Hum Reprod Update,1998,4(5):503-508
  • 6Abberton KM,Taylor NH,Healy DL,et al.Vascular smooth muscle cell proliferation in arterioles of the human endometrium.Hum Reprod,1999,14(4):1072-1079
  • 7Sangha RK,Li XF,Shams M,et al.Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling:localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia.Lab Invest,1997,77(4):389-402
  • 8Meduri G,Bausero P,Perrot-Applanat M.Expression of vascular endothelial growth factor receptors in the human endometrium:modulation during the menstrual cycle.Biol Reprod,2000,62(2):439-447
  • 9Smith SK.Angiogenesis,vascular endothelial growth factor and the endometrium.Hum Reprod Update,1998,4(5):509-519
  • 10Hurskainen R,Teperi J,Paavonnen J,et al.Menorrhagia and uterine artery blood flow.Hum Reprod,1999,14(1):186-189

共引文献396

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部